Genome-wide expression analysis suggests unique disease-promoting and disease-preventing signatures in Pemphigus vulgaris

Genes and Immunity

Volumn 14, Issue 8, 2013, Pages 487-499

  Dey Rao, R ^a   Seiffert Sinha, K ^a   Sinha, A A ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

autoimmune disease; disease signatures; DNA microarray; gene expression; HLA; pemphigus vulgaris

Indexed keywords

HLA ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE;

ADULT; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; HUMAN; IMMUNE RESPONSE; MALE; OXIDATION REDUCTION STATE; PATHOGENESIS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; PEMPHIGUS; TRANSCRIPTOME;

EID: 84889686155     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2013.44     Document Type: Article

References (62)

1. Gupta VK, Kelbel TE, Nguyen D, Melonakos KC, Murrell DF, Xie Y et al. A globally available internet-based patient survey of pemphigus vulgaris: epidemiology and disease characteristics. Dermatol Clin 2011; 29: 393-404.
2. Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJ, West J. Bullous pemphigoid and pemphigus vulgaris-incidence and mortality in the UK: population based cohort study. BMJ 2008; 337: a180.
3. Bystryn JC, Rudolph JL. Pemphigus. Lancet 2005; 366: 61-73.
4. Sinha AA. The genetics of pemphigus. Dermatol Clin 2011; 29: 381-391.
5. Coda AB, Qafalijaj Hysa V, Seiffert-Sinha K, Sinha AA. Peripheral blood gene expression in alopecia areata reveals molecular pathways distinguishing heritability, disease and severity. Genes Immunity 2010; 11: 531-541.
6. Kunz M. DNA microarray technology in dermatology. Semin Cutan Med Surg 2008; 27: 16-24.
7. Oertelt S, Selmi C, Invernizzi P, Podda M, Gershwin ME. Genes and goals: an approach to microarray analysis in autoimmunity. Autoimmunity Rev 2005; 4: 414-422.
8. Orban T, Kis J, Szereday L, Engelmann P, Farkas K, Jalahej H et al. Reduced CD4\+ T-cell-specific gene expression in human type 1 diabetes mellitus. J Autoimmun 2007; 28: 177-187.
9. Fossey SC, Vnencak-Jones CL, Olsen NJ, Sriram S, Garrison G, Deng X et al. Identification of molecular biomarkers for multiple sclerosis. J Mol Diagn 2007; 9: 197-204.
10. Sinha AA, Lopez MT, McDevitt HO. Autoimmune diseases: the failure of self tolerance. Science 1990; 248: 1380-1388.
11. Murrell DF, Dick S, Ahmed AR, Amagai M, Barnadas MA, Borradori L et al. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol 2008; 58: 1043-1046.
12. Rizzo C, Fotino M, Zhang Y, Chow S, Spizuoco A, Sinha AA. Direct characterization of human T cells in pemphigus vulgaris reveals elevated autoantigen-specific Th2 activity in association with active disease. Clin Exper Dermatol 2005; 30: 535-540.
13. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008; 28: 454-467.
14. Paunovic V, Carroll HP, Vandenbroeck K, Gadina M. Signalling, inflammation and arthritis: crossed signals: the role of interleukin (IL)-12,-17,-23 and-27 in autoimmunity. Rheumatology (Oxford) 2008; 47: 771-776.
15. Grando SA, Bystryn JC, Chernyavsky AI, Frusic-Zlotkin M, Gniadecki R, Lotti R et al. Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis. Exp Dermatol 2009; 18: 764-770.
16. Bektas M, Jolly P, Rubenstein DS. Apoptotic pathways in pemphigus. Dermatol Res Practice 2010; 2010: 456841.
17. Grando SA, Glukhenky BT, Drannik GN, Epshtein EV, Kostromin AP, Korostash TA. Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid. Arch Dermatol 1989; 125: 925-930.
18. Takahashi H, Kouno M, Nagao K, Wada N, Hata T, Nishimoto S et al. Desmoglein 3-specific CD4\+ T cells induce pemphigus vulgaris and interface dermatitis in mice. J Clin Invest 2011; 121: 3677-3688.
19. Bystryn JC, Grando S. The cause of acantholysis in pemphigus: further support for the 'basal cell shrinkage' hypothesis. Br J Dermatol 2009; 161: 702.
20. Lotti R, Marconi A, Pincelli C. Apoptotic pathways in the pathogenesis of pemphigus: targets for new therapies. Curr Pharm Biotechnol 2012; 13: 1877-1881.
21. Majore S, Biolcati G, Barboni L, Cannistraci C, Binni F, Crisi A et al. ATP2C1 gene mutation analysis in Italian patients with Hailey-Hailey disease. J Invest Dermatol 2005; 125: 933-935.
22. Kalantari-Dehaghi M, Anhalt GJ, Camilleri MJ, Chernyavsky AI, Chun S, Felgner PL et al. Pemphigus vulgaris autoantibody profiling by proteomic technique. PLoS One 2013; 8: e57587.
23. Kitajima Y. Mechanisms of desmosome assembly and disassembly. Clin Exp Dermatol 2002; 27: 684-690.
24. Steinhusen U, Weiske J, Badock V, Tauber R, Bommert K, Huber O. Cleavage and shedding of E-cadherin after induction of apoptosis. J Biol Chem 2001; 276: 4972-4980.
25. Dusek RL, Getsios S, Chen F, Park JK, Amargo EV, Cryns VL et al. The differentiation-dependent desmosomal cadherin desmoglein 1 is a novel caspase-3 target that regulates apoptosis in keratinocytes. J Biol Chem 2006; 281: 3614-3624.
26. Amagai M. Pemphigus as a paradigm of autoimmunity and cell adhesion. Keio J Med 2002; 51: 133-139.
27. Ellebrecht CT, Srinivas G, Bieber K, Banczyk D, Kinzel S, Kalies K et al. Microbial diversity and cutaneous inflammation are predictive for the clinical course of experimental epidermolysis bullosa acquisita. J Invest Dermatol 2013; 133 (Supplement 1): S21.
28. Sarig O, Bercovici S, Zoller L, Goldberg I, Indelman M, Nahum S et al. Populationspecific association between a polymorphic variant in ST18, encoding a proapoptotic molecule, and pemphigus vulgaris. J Invest Dermatol 2012; 132: 1798-1805.
29. Lanza A, Cirillo N, Rossiello R, Rienzo M, Cutillo L, Casamassimi A et al. Evidence of key role of Cdk2 overexpression in pemphigus vulgaris. J Biol Chem 2008; 283: 8736-8745.
30. Cirillo N, Lanza M, Rossiello L, Gombos F, Lanza A. Defining the involvement of proteinases in pemphigus vulgaris: evidence of matrix metalloproteinase-9 overexpression in experimental models of disease. J Cell Physiol 2007; 212: 36-41.
31. Nguyen VT, Arredondo J, Chernyavsky AI, Kitajima Y, Pittelkow M, Grando SA. Pemphigus vulgaris IgG and methylprednisolone exhibit reciprocal effects on keratinocytes. J Biol Chem 2004; 279: 2135-2146.
32. Sinha AA, Brautbar C, Szafer F, Friedmann A, Tzfoni E, Todd JA et al. A newly characterized HLA DQ beta allele associated with pemphigus vulgaris. Science 1988; 239: 1026-1029.
33. Tron F, Gilbert D, Mouquet H, Joly P, Drouot L, Makni S et al. Genetic factors in pemphigus. J Autoimmun 2005; 24: 319-328.
34. Lee E, Lendas KA, Chow S, Pirani Y, Gordon D, Dionisio R et al. Disease relevant HLA class II alleles isolated by genotypic, haplotypic, and sequence analysis in North American Caucasians with pemphigus vulgaris. Hum Immunol 2006; 67: 125-139.
35. Sarig O, Vodo D, Rosser Sea. A GWAS analysis identifies non-HLA genes within the MHC locus as associated with pemphigus vulgaris. J Invest Dermatol 2013; 133(Supplement 1): s34.
36. Waschke J, Spindler V, Bruggeman P, Zillikens D, Schmidt G, Drenckhahn D. Inhibition of Rho A activity causes pemphigus skin blistering. J Cell Biol 2006; 175: 721-727.
37. Berkowitz P, Hu P, Warren S, Liu Z, Diaz LA, Rubenstein DS. p38MAPK inhibition prevents disease in pemphigus vulgaris mice. Proc Natl Acad Sci USA 2006; 103: 12855-12860.
38. Jolly PS, Berkowitz P, Bektas M, Lee HE, Chua M, Diaz LA et al. p38MAPK signaling and desmoglein-3 internalization are linked events in pemphigus acantholysis. J Biol Chem 2010; 285: 8936-8941.
39. Marchenko S, Chernyavsky AI, Arredondo J, Gindi V, Grando SA. Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology. J Biol Chem 2010; 285: 3695-3704.
40. Spindler V, Drenckhahn D, Zillikens D, Waschke J. Pemphigus IgG causes skin splitting in the presence of both desmoglein 1 and desmoglein 3. Am J Pathol 2007; 171: 906-916.
41. Williamson L, Raess NA, Caldelari R, Zakher A, de Bruin A, Posthaus H et al. Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin. EMBO J 2006; 25: 3298-3309.
42. Chernyavsky AI, Arredondo J, Piser T, Karlsson E, Grando SA. Differential coupling of M1 muscarinic and alpha7 nicotinic receptors to inhibition of pemphigus acantholysis. J Biol Chem 2008; 283: 3401-3408.
43. Moon SY, Zheng Y. Rho GTPase-activating proteins in cell regulation. Trends Cell Biol 2003; 13: 13-22.
44. Jaffe AB, Hall A. Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 2005; 21: 247-269.
45. Best A, Ahmed S, Kozma R, Lim L. The Ras-related GTPase Rac1 binds tubulin. J Biol Chem 1996; 271: 3756-3762.
46. Fania L, Zampetti A, Guerriero G, Feliciani C. Alteration of cholinergic system in keratinocites cells produces acantholysis: a possible use of cholinergic drugs in Pemphigus Vulgaris. Anti-inflamm Anti-allergy Agents Med Chem 2012; 11: 238-242.
47. Chernyavsky AI, Nguyen VT, Arredondo J, Ndoye A, Zia S, Wess J et al. The M4 muscarinic receptor-selective effects on keratinocyte crawling locomotion. Life Sci 2003; 72: 2069-2073.
48. Grando SA. Pemphigus in the XXI century: new life to an old story. Autoimmunity 2006; 39: 521-530.
49. Nguyen VT, Ndoye A, Grando SA. Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity. Am J Pathol 2000; 157: 1377-1391.
50. Grando SA. Pemphigus autoimmunity: hypotheses and realities. Autoimmunity 2012; 45: 7-35.
51. Hassfeld W, Steiner G, Studnicka-Benke A, Skriner K, Graninger W, Fischer I et al. Autoimmune response to the spliceosome. An immunologic link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus. Arthritis Rheum 1995; 38: 777-785.
52. Gliem M, Heupel WM, Spindler V, Harms GS, Waschke J. Actin reorganization contributes to loss of cell adhesion in pemphigus vulgaris. Am J Physiol Cell Physiol 2010; 299: C606-C613.
53. Zhang L, Deng M, Parthasarathy R, Wang L, Mongan M, Molkentin JD et al. MEKK1 transduces activin signals in keratinocytes to induce actin stress fiber formation and migration. Mol Cell Biol 2005; 25: 60-65.
54. Zanet J, Freije A, Ruiz M, Coulon V, Sanz JR, Chiesa J et al. A mitosis block links active cell cycle with human epidermal differentiation and results in endoreplication. PLoS One 2010; 5: e15701.
55. Chen R, Morgan AA, Dudley J, Deshpande T, Li L, Kodama K et al. FitSNPs: highly differentially expressed genes are more likely to have variants associated with disease. Genome Biol 2008; 9: R170.
56. London B, Michalec M, Mehdi H, Zhu X, Kerchner L, Sanyal S et al. Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na\+ current and causes inherited arrhythmias. Circulation 2007; 116: 2260-2268.
57. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequencespecific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-235.
58. Coda AB, Icen M, Smith JR, Sinha AA. Global transcriptional analysis of psoriatic skin and blood confirms known disease-associated pathways and highlights novel genomic 'hot spots' for differentially expressed genes. Genomics 2012; 100: 18-26.
59. Benjamini Y. Controlling the False DIscovery Rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B 1995; 57: 289-300.
60. Huang da W, Sherman BT, Tan Q, Kir J, Liu D, Bryant D et al. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res 2007; 35: Web Server issue W169-W175.
61. Shmelkov E, Tang Z, Aifantis I, Statnikov A. Assessing quality and completeness of human transcriptional regulatory pathways on a genome-wide scale. Biol Direct 2011; 6: 15.
62. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.